Neuromodulatory treatment of recalcitrant plaque psoriasis with onabotulinumtoxinA

J Am Acad Dermatol. 2018 Dec;79(6):1156-1159. doi: 10.1016/j.jaad.2018.07.058.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Botulinum Toxins, Type A / therapeutic use*
  • Calcitonin Gene-Related Peptide / analysis
  • Drug Resistance
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nerve Fibers / pathology
  • Neurotransmitter Agents / therapeutic use*
  • Pilot Projects
  • Psoriasis / drug therapy*
  • Psoriasis / pathology
  • Severity of Illness Index
  • Skin / innervation
  • Skin / pathology
  • Substance P / analysis

Substances

  • Neurotransmitter Agents
  • Substance P
  • Botulinum Toxins, Type A
  • onabotulinum toxin A
  • Calcitonin Gene-Related Peptide